1999 Fiscal Year Final Research Report Summary
Structure and properties of Max protein which regulates the function of a proto-oncogene product, c-Myc
Project/Area Number |
09470492
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Physical pharmacy
|
Research Institution | Yokohama National University |
Principal Investigator |
UESUGI Seiichi Yokohama National University, Faculty of Engineering, Professor, 工学部, 教授 (70028851)
|
Co-Investigator(Kenkyū-buntansha) |
KURIHARA Yasuyuki Yokohama National University, Faculty of Engineering, Research Associate, 工学部, 助手 (80202050)
|
Project Period (FY) |
1997 – 1999
|
Keywords | proto-oncogene / DNA binding protein / transcription factor / c-Myc / Max / mutant protein / DNA-porotein interaction / structure |
Research Abstract |
Max Protein regulates the function of a proto-oncogene product, Myc, by formation of a heterodimer with Myc or a homodimer with itself and binding to DNA. We established a procedure for preparation of Max and two types of its DNA binding domains by genetic engineering techniques and examined their structure and properties. Max proteins were in equilibrium between a monomer and a dimer in solution. The dimer content increasesd with increasing protein concentration and decreasing temperature. Increase in α-helical content of the protein simultaneously accompanied the dimer increase. Upon addition of a duplex DNA containing the specific recognition base sequence, the α-helical content increased further with increasing DNA concentration. When a DNA duplex containing a sequence different in the central two base pairs was used, the α-helical content increase was smaller. A strictly specific recognition of the cognate sequence was observed at high temperature. The biological activity of Max is modulated by phosphorylation of Ser residues in the N-terminal region. We prepared mutant proteins where one or two of the Ser residues were replaced with Asp residue(s) as a mimic of the phosophorylated Max and examined DNA binding ability of the mutant proteins. The mutant protein-DNA complexes showed lower stability and the complex of the mutant protein with double mutation showed the lowest stability. We also developed a synthetic method for obtaining phosphorylated Max by chemically joining a phosphorylated peptied synthesized chemically and the remaining part of protein prepared by genetic engineering.
|
Research Products
(4 results)